{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T02:13:45Z","timestamp":1785204825703,"version":"3.55.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-024-13154-0","type":"journal-article","created":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T01:09:45Z","timestamp":1731719385000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Exploring the correlation between Tom1L1 and the efficacy of neoadjuvant chemotherapy for locally progressive mid-low rectal cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Meng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueliang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Yubo\u00a0Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Likun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,16]]},"reference":[{"key":"13154_CR1","doi-asserted-by":"publisher","first-page":"175883591985344","DOI":"10.1177\/1758835919853449","volume":"11","author":"Z Yang","year":"2019","unstructured":"Yang Z, Jiang S, Lu C, Ji T, Yang W, Li T, Lv J, Hu W, Yang Y, Jin Z. SOX11: friend or foe in tumor prevention and carcinogenesis? Ther Adv Med Oncol. 2019;11:1758835919853449.","journal-title":"Ther Adv Med Oncol"},{"issue":"6","key":"13154_CR2","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s10495-016-1244-3","volume":"21","author":"W Hu","year":"2016","unstructured":"Hu W, Yang Y, Fan C, Ma Z, Deng C, Li T, Lv J, Yao W, Gao J. Clinical and pathological significance of N-Myc downstream-regulated gene 2 (NDRG2) in diverse human cancers. Apoptosis. 2016;21(6):675\u201382.","journal-title":"Apoptosis"},{"key":"13154_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106777","volume":"191","author":"X Zhang","year":"2023","unstructured":"Zhang X, Yu S, Li X, Wen X, Liu S, Zu R, Ren H, Li T, Yang C, Luo H. Research progress on the interaction between oxidative stress and platelets: Another avenue for cancer? Pharmacol Res. 2023;191: 106777.","journal-title":"Pharmacol Res"},{"issue":"3","key":"13154_CR4","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3322\/caac.21838","volume":"74","author":"N Jokhadze","year":"2024","unstructured":"Jokhadze N, Das A, Dizon DS. Global cancer statistics: A healthy population relies on population health. CA Cancer J Clin. 2024;74(3):224\u20136.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"13154_CR5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"13154_CR6","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1186\/s12885-024-12508-y","volume":"24","author":"Y Feng","year":"2024","unstructured":"Feng Y, Wang K, Fan J, Wu X, Li T, Yang Z. Mindfulness intervention, homogeneous medical concept, and concentrated solution nursing for colorectal cancer patients: a retrospective study. BMC Cancer. 2024;24(1):1055.","journal-title":"BMC Cancer"},{"issue":"2","key":"13154_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.32604\/or.2023.028657","volume":"31","author":"X Wu","year":"2023","unstructured":"Wu X, Guan S, Lu Y, Xue J, Yu X, Zhang QI, Wang X, Li T. Macrophage-derived SHP-2 inhibits the metastasis of colorectal cancer via Tie2-PI3K signals. Oncol Res. 2023;31(2):125\u201339.","journal-title":"Oncol Res"},{"key":"13154_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.935500","volume":"13","author":"Y Niu","year":"2022","unstructured":"Niu Y, Xue J, Wu X, Qu M, Wang L, Liang W, Li T. Clinical Significance of Serum Haptoglobin and Protein Disulfide-Isomerase A3 in the Screening, Diagnosis, and Staging of Colorectal Cancer. Front Pharmacol. 2022;13: 935500.","journal-title":"Front Pharmacol"},{"issue":"1","key":"13154_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jncc.2022.02.002","volume":"2","author":"R Zheng","year":"2022","unstructured":"Zheng R, Zhang S, Zeng H, Wang S, Sun K, Chen R, Li L, Wei W, He J. Cancer incidence and mortality in China, 2016. Journal of the National Cancer Center. 2022;2(1):1\u20139.","journal-title":"Journal of the National Cancer Center"},{"issue":"6","key":"13154_CR10","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.ctrv.2014.02.006","volume":"40","author":"DL Nielsen","year":"2014","unstructured":"Nielsen DL, Palshof JA, Larsen FO, Jensen BV, Pfeiffer P. A systematic review of salvage therapy to patients with metastatic colorectal cancer previously treated with fluorouracil, oxaliplatin and irinotecan +\/- targeted therapy. Cancer Treat Rev. 2014;40(6):701\u201315.","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"13154_CR11","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/annonc\/mdt591","volume":"25","author":"N Hugen","year":"2014","unstructured":"Hugen N, van de Velde CJH, de Wilt JHW, Nagtegaal ID. Metastatic pattern in colorectal cancer is strongly influenced by histological subtype. Ann Oncol. 2014;25(3):651\u20137.","journal-title":"Ann Oncol"},{"issue":"5","key":"13154_CR12","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/BF02367787","volume":"30","author":"M Katoh","year":"1995","unstructured":"Katoh M, Unakami M, Hara M, Fukuchi S. Bone metastasis from colorectal cancer in autopsy cases. J Gastroenterol. 1995;30(5):615\u20138.","journal-title":"J Gastroenterol"},{"issue":"7","key":"13154_CR13","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s00595-012-0450-z","volume":"43","author":"S Jimi","year":"2013","unstructured":"Jimi S, Yasui T, Hotokezaka M, Shimada K, Shinagawa Y, Shiozaki H, Tsutsumi N, Takeda S. Clinical features and prognostic factors of bone metastases from colorectal cancer. Surg Today. 2013;43(7):751\u20136.","journal-title":"Surg Today"},{"issue":"8","key":"13154_CR14","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1002\/cncr.29196","volume":"121","author":"R Yaeger","year":"2015","unstructured":"Yaeger R, Cowell E, Chou JF, Gewirtz AN, Borsu L, Vakiani E, Solit DB, Rosen N, Capanu M, Ladanyi M, et al. RAS mutations affect pattern of metastatic spread and increase propensity for brain metastasis in colorectal cancer. Cancer. 2015;121(8):1195\u2013203.","journal-title":"Cancer"},{"key":"13154_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jbo.2018.09.009","volume":"13","author":"TD Christensen","year":"2018","unstructured":"Christensen TD, Jensen SG, Larsen FO, Nielsen DL. Systematic review: Incidence, risk factors, survival and treatment of bone metastases from colorectal cancer. J Bone Oncol. 2018;13:97\u2013105.","journal-title":"J Bone Oncol"},{"issue":"8","key":"13154_CR16","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1093\/annonc\/mdr572","volume":"23","author":"D Santini","year":"2012","unstructured":"Santini D, Tampellini M, Vincenzi B, Ibrahim T, Ortega C, Virzi V, Silvestris N, Berardi R, Masini C, Calipari N, et al. Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study. Ann Oncol. 2012;23(8):2072\u20137.","journal-title":"Ann Oncol"},{"key":"13154_CR17","doi-asserted-by":"publisher","first-page":"6851900","DOI":"10.1155\/2022\/6851900","volume":"2022","author":"L Shan","year":"2022","unstructured":"Shan L, Li T, Gu W, Gao Y, Zuo E, Qiu H, Li R, Cheng X. Application of Prognostic Models Based on Psoas Muscle Index, Stage, Pathological Grade, and Preoperative Carcinoembryonic Antigen Level in Stage II-III Colorectal Cancer Patients Undergoing Adjuvant Chemotherapy. J Oncol. 2022;2022:6851900.","journal-title":"J Oncol"},{"key":"13154_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.713335","volume":"12","author":"L Wang","year":"2022","unstructured":"Wang L, Wu X, Xu W, Gao L, Wang X, Li T. Combined Detection of RUNX3 and EZH2 in Evaluating Efficacy of Neoadjuvant Therapy and Prognostic Value of Middle and Low Locally Advanced Rectal Cancer. Front Oncol. 2022;12: 713335.","journal-title":"Front Oncol"},{"key":"13154_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114285","volume":"189","author":"M Sun","year":"2021","unstructured":"Sun M, Liu X, Xia L, Chen Y, Kuang L, Gu X, Li T. A nine-lncRNA signature predicts distant relapse-free survival of HER2-negative breast cancer patients receiving taxane and anthracycline-based neoadjuvant chemotherapy. Biochem Pharmacol. 2021;189: 114285.","journal-title":"Biochem Pharmacol"},{"issue":"12","key":"13154_CR20","doi-asserted-by":"publisher","first-page":"djw171","DOI":"10.1093\/jnci\/djw171","volume":"108","author":"MH Martens","year":"2016","unstructured":"Martens MH, Maas M, Heijnen LA, Lambregts DM, Leijtens JW, Stassen LP, Breukink SO, Hoff C, Belgers EJ, Melenhorst J, et al. Long-term Outcome of an Organ Preservation Program After Neoadjuvant Treatment for Rectal Cancer. J Natl Cancer. 2016;108(12):djw171.","journal-title":"J Natl Cancer"},{"issue":"8","key":"13154_CR21","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.7150\/ijbs.15438","volume":"12","author":"Y Li","year":"2016","unstructured":"Li Y, Wang J, Ma X, Tan L, Yan Y, Xue C, Hui B, Liu R, Ma H, Ren J. A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer. Int J Biol Sci. 2016;12(8):1022\u201331.","journal-title":"Int J Biol Sci"},{"key":"13154_CR22","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/921435","volume":"2015","author":"R Conde-Mu\u00ed\u00f1o","year":"2015","unstructured":"Conde-Mu\u00ed\u00f1o R, Cuadros M, Zambudio N, Segura-Jim\u00e9nez I, Cano C, Palma P. Predictive Biomarkers to Chemoradiation in Locally Advanced Rectal Cancer. Biomed Res Int. 2015;2015: 921435.","journal-title":"Biomed Res Int"},{"issue":"19","key":"13154_CR23","doi-asserted-by":"publisher","first-page":"7040","DOI":"10.3390\/ijms21197040","volume":"21","author":"FDE De Palma","year":"2020","unstructured":"De Palma FDE, Luglio G, Tropeano FP, Pagano G, D\u2019Armiento M, Kroemer G, Maiuri MC, De Palma GD. The Role of Micro-RNAs and Circulating Tumor Markers as Predictors of Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer. Int J Mol Sci. 2020;21(19):7040.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"13154_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrm.2016.121","volume":"18","author":"J Sch\u00f6neberg","year":"2017","unstructured":"Sch\u00f6neberg J, Lee IH, Iwasa JH, Hurley JH. Reverse-topology membrane scission by the ESCRT proteins. Nat Rev Mol Cell Biol. 2017;18(1):5\u201317.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"13154_CR25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1247\/csf.07037","volume":"33","author":"Y Yanagida-Ishizaki","year":"2008","unstructured":"Yanagida-Ishizaki Y, Takei T, Ishizaki R, Imakagura H, Takahashi S, Shin HW, Katoh Y, Nakayama K. Recruitment of Tom1L1\/Srcasm to endosomes and the midbody by Tsg101. Cell Struct Funct. 2008;33(1):91\u2013100.","journal-title":"Cell Struct Funct"},{"issue":"4","key":"13154_CR26","doi-asserted-by":"publisher","first-page":"e201808181","DOI":"10.1083\/jcb.201808181","volume":"221","author":"R Cabral-Dias","year":"2022","unstructured":"Cabral-Dias R, Lucarelli S, Zak K, Rahmani S, Judge G, Abousawan J, DiGiovanni LF, Vural D, Anderson KE, Sugiyama MG, et al. Fyn and TOM1L1 are recruited to clathrin-coated pits and regulate Akt signaling. J Cell Biol. 2022;221(4):e201808181.","journal-title":"J Cell Biol"},{"issue":"6","key":"13154_CR27","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1007\/s13304-021-01124-1","volume":"73","author":"WRG Perry","year":"2021","unstructured":"Perry WRG. Abd El Aziz MA, Duchalais E, Grass F, Behm KT, Mathis KL, Kelley SR: Sexual dysfunction following surgery for rectal cancer: a single-institution experience. Updates Surg. 2021;73(6):2155\u20139.","journal-title":"Updates Surg"},{"issue":"9","key":"13154_CR28","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/S1470-2045(10)70172-8","volume":"11","author":"M Maas","year":"2010","unstructured":"Maas M, Nelemans PJ, Valentini V, Das P, R\u00f6del C, Kuo LJ, Calvo FA, Garc\u00eda-Aguilar J, Glynne-Jones R, Haustermans K, et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol. 2010;11(9):835\u201344.","journal-title":"Lancet Oncol"},{"issue":"35","key":"13154_CR29","doi-asserted-by":"publisher","first-page":"38360","DOI":"10.18632\/oncotarget.5256","volume":"6","author":"P Carpinetti","year":"2015","unstructured":"Carpinetti P, Donnard E, Bettoni F, Asprino P, Koyama F, Rozanski A, Sabbaga J, Habr-Gama A, Parmigiani RB, Galante PA, et al. The use of personalized biomarkers and liquid biopsies to monitor treatment response and disease recurrence in locally advanced rectal cancer after neoadjuvant chemoradiation. Oncotarget. 2015;6(35):38360\u201371.","journal-title":"Oncotarget"},{"issue":"12","key":"13154_CR30","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.30097","volume":"3","author":"A Kasi","year":"2020","unstructured":"Kasi A, Abbasi S, Handa S, Al-Rajabi R, Saeed A, Baranda J, Sun W. Total Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysis. JAMA Netw Open. 2020;3(12): e2030097.","journal-title":"JAMA Netw Open"},{"issue":"7","key":"13154_CR31","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1007\/s00384-022-04193-9","volume":"37","author":"IJ Yang","year":"2022","unstructured":"Yang IJ, Suh JW, Lee J, Ahn HM, Oh HK, Kim DW, Kim MJ, Ryoo SB, Jeong SY, Park KJ, et al. Comparison of tumor regression grade and clinical stage based on MRI image as a selection criterion for non-radical management after concurrent chemoradiotherapy in locally advanced rectal cancer: a multicenter, retrospective, cross-sectional study. Int J Colorectal Dis. 2022;37(7):1561\u20138.","journal-title":"Int J Colorectal Dis"},{"issue":"4","key":"13154_CR32","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1097\/SLA.0000000000001193","volume":"263","author":"NJ Battersby","year":"2016","unstructured":"Battersby NJ, How P, Moran B, Stelzner S, West NP, Branagan G, Strassburg J, Quirke P, Tekkis P, Pedersen BG, et al. Prospective Validation of a Low Rectal Cancer Magnetic Resonance Imaging Staging System and Development of a Local Recurrence Risk Stratification Model: The MERCURY II Study. Ann Surg. 2016;263(4):751\u201360.","journal-title":"Ann Surg"},{"issue":"Suppl 4","key":"13154_CR33","doi-asserted-by":"publisher","first-page":"iv263","DOI":"10.1093\/annonc\/mdy161","volume":"29","author":"R Glynne-Jones","year":"2018","unstructured":"Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, R\u00f6del C, Cervantes A, Arnold D. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl 4):iv263.","journal-title":"Ann Oncol"},{"issue":"7","key":"13154_CR34","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/bjs.8732","volume":"99","author":"R Glynne-Jones","year":"2012","unstructured":"Glynne-Jones R, Hughes R. Critical appraisal of the \u201cwait and see\u201d approach in rectal cancer for clinical complete responders after chemoradiation. Br J Surg. 2012;99(7):897\u2013909.","journal-title":"Br J Surg"},{"issue":"suppl_4","key":"13154_CR35","doi-asserted-by":"publisher","first-page":"iv22","DOI":"10.1093\/annonc\/mdx224","volume":"28","author":"R Glynne-Jones","year":"2017","unstructured":"Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, R\u00f6del C, Cervantes A, Arnold D. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28(suppl_4):iv22\u201340.","journal-title":"Ann Oncol"},{"issue":"6","key":"13154_CR36","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1097\/SLA.0000000000002761","volume":"268","author":"M Dattani","year":"2018","unstructured":"Dattani M, Heald RJ, Goussous G, Broadhurst J, S\u00e3o Juli\u00e3o GP, Habr-Gama A, Perez RO, Moran BJ. Oncological and Survival Outcomes in Watch and Wait Patients With a Clinical Complete Response After Neoadjuvant Chemoradiotherapy for Rectal Cancer: A Systematic Review and Pooled Analysis. Ann Surg. 2018;268(6):955\u201367.","journal-title":"Ann Surg"},{"issue":"12","key":"13154_CR37","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/S2468-1253(18)30301-7","volume":"3","author":"SA Chadi","year":"2018","unstructured":"Chadi SA, Malcomson L, Ensor J, Riley RD, Vaccaro CA, Rossi GL, Daniels IR, Smart NJ, Osborne ME, Beets GL, et al. Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis. Lancet Gastroenterol Hepatol. 2018;3(12):825\u201336.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"13154_CR38","doi-asserted-by":"publisher","first-page":"272","DOI":"10.21147\/j.issn.1000-9604.2018.02.10","volume":"30","author":"Z Lu","year":"2018","unstructured":"Lu Z, Cheng P, Yang F, Zheng Z, Wang X. Long-term outcomes in patients with ypT0 rectal cancer after neoadjuvant chemoradiotherapy and curative resection. Chin J Cancer Res. 2018;30(2):272\u201381.","journal-title":"Chin J Cancer Res"},{"issue":"4","key":"13154_CR39","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1007\/s00464-021-08932-x","volume":"36","author":"X Zhang","year":"2022","unstructured":"Zhang X, Ding R, Li J, Wu T, Shen Z, Li S, Zhang Y, Dong C, Shang Z, Zhou H, et al. Efficacy and safety of the \u201cwatch-and-wait\u201d approach for rectal cancer with clinical complete response after neoadjuvant chemoradiotherapy: a meta-analysis. Surg Endosc. 2022;36(4):2233\u201344.","journal-title":"Surg Endosc"},{"issue":"1","key":"13154_CR40","doi-asserted-by":"publisher","first-page":"16","DOI":"10.21614\/chirurgia.116.1.16","volume":"116","author":"MT Georgescu","year":"2021","unstructured":"Georgescu MT, Patrascu T, Serbanescu LG, Anghel RM, Gales LN, Georgescu FT, Mitrica RI, Georgescu DE. When Should We Expect Curative Results of Neoadjuvant Treatment in Locally Advanced Rectal Cancer Patients? Chirurgia (Bucur). 2021;116(1):16\u201323.","journal-title":"Chirurgia (Bucur)"},{"issue":"5","key":"13154_CR41","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1245\/s10434-012-2773-9","volume":"20","author":"H Tranchart","year":"2013","unstructured":"Tranchart H, Lef\u00e8vre JH, Svrcek M, Flejou JF, Tiret E, Parc Y. What is the incidence of metastatic lymph node involvement after significant pathologic response of primary tumor following neoadjuvant treatment for locally advanced rectal cancer? Ann Surg Oncol. 2013;20(5):1551\u20139.","journal-title":"Ann Surg Oncol"},{"key":"13154_CR42","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/1477-7819-12-197","volume":"12","author":"JM Chiang","year":"2014","unstructured":"Chiang JM, Hsieh PS, Chen JS, Tang R, You JF, Yeh CY. Rectal cancer level significantly affects rates and patterns of distant metastases among rectal cancer patients post curative-intent surgery without neoadjuvant therapy. World J Surg Oncol. 2014;12:197.","journal-title":"World J Surg Oncol"},{"issue":"4","key":"13154_CR43","doi-asserted-by":"publisher","DOI":"10.1080\/23723556.2016.1182241","volume":"3","author":"C Chevalier","year":"2016","unstructured":"Chevalier C, Roche S, B\u00e9nistant C. Vesicular trafficking regulators are new players in breast cancer progression: Role of TOM1L1 in ERBB2-dependent invasion. Mol Cell Oncol. 2016;3(4): e1182241.","journal-title":"Mol Cell Oncol"},{"key":"13154_CR44","doi-asserted-by":"publisher","first-page":"10765","DOI":"10.1038\/ncomms10765","volume":"7","author":"C Chevalier","year":"2016","unstructured":"Chevalier C, Collin G, Descamps S, Touaitahuata H, Simon V, Reymond N, Fernandez L, Milhiet PE, Georget V, Urbach S, et al. TOM1L1 drives membrane delivery of MT1-MMP to promote ERBB2-induced breast cancer cell invasion. Nat Commun. 2016;7:10765.","journal-title":"Nat Commun"},{"issue":"12","key":"13154_CR45","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1074\/mcp.M112.018168","volume":"11","author":"A Sirvent","year":"2012","unstructured":"Sirvent A, Vigy O, Orsetti B, Urbach S, Roche S. Analysis of SRC oncogenic signaling in colorectal cancer by stable isotope labeling with heavy amino acids in mouse xenografts. Mol Cell Proteomics. 2012;11(12):1937\u201350.","journal-title":"Mol Cell Proteomics"},{"issue":"21","key":"13154_CR46","doi-asserted-by":"publisher","first-page":"7631","DOI":"10.1128\/MCB.00543-07","volume":"27","author":"G Collin","year":"2007","unstructured":"Collin G, Franco M, Simon V, B\u00e9nistant C, Roche S. The Tom1L1-clathrin heavy chain complex regulates membrane partitioning of the tyrosine kinase Src required for mitogenic and transforming activities. Mol Cell Biol. 2007;27(21):7631\u201340.","journal-title":"Mol Cell Biol"},{"key":"13154_CR47","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12920-014-0068-7","volume":"7","author":"CM Lopes-Ramos","year":"2014","unstructured":"Lopes-Ramos CM, Habr-Gama A, Quevedo Bde S, Fel\u00edcio NM, Bettoni F, Koyama FC, Asprino PF, Galante PA, Gama-Rodrigues J, Camargo AA, et al. Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients. BMC Med Genomics. 2014;7:68.","journal-title":"BMC Med Genomics"},{"issue":"12","key":"13154_CR48","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.1158\/1078-0432.CCR-08-3257","volume":"15","author":"N Yamamichi","year":"2009","unstructured":"Yamamichi N, Shimomura R, Inada K, Sakurai K, Haraguchi T, Ozaki Y, Fujita S, Mizutani T, Furukawa C, Fujishiro M, et al. Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development. Clin Cancer Res. 2009;15(12):4009\u201316.","journal-title":"Clin Cancer Res"},{"key":"13154_CR49","doi-asserted-by":"publisher","first-page":"812","DOI":"10.3389\/fcell.2020.00812","volume":"8","author":"X Wu","year":"2020","unstructured":"Wu X, Yan F, Wang L, Sun G, Liu J, Qu M, Wang Y, Li T. MicroRNA: Another Pharmacological Avenue for Colorectal Cancer? Front Cell Dev Biol. 2020;8:812.","journal-title":"Front Cell Dev Biol"},{"issue":"10","key":"13154_CR50","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/nrg2634","volume":"10","author":"CM Croce","year":"2009","unstructured":"Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet. 2009;10(10):704\u201314.","journal-title":"Nat Rev Genet"},{"issue":"5","key":"13154_CR51","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1136\/gut.2011.239236","volume":"61","author":"CW Wu","year":"2012","unstructured":"Wu CW, Ng SS, Dong YJ, Ng SC, Leung WW, Lee CW, Wong YN, Chan FK, Yu J, Sung JJ. Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps. Gut. 2012;61(5):739\u201345.","journal-title":"Gut"},{"issue":"2","key":"13154_CR52","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1593\/tlo.12397","volume":"6","author":"Y Yu","year":"2013","unstructured":"Yu Y, Sarkar FH, Majumdar AP. Down-regulation of miR-21 Induces Differentiation of Chemoresistant Colon Cancer Cells and Enhances Susceptibility to Therapeutic Regimens. Transl Oncol. 2013;6(2):180\u20136.","journal-title":"Transl Oncol"},{"issue":"1","key":"13154_CR53","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/bjc.2015.168","volume":"113","author":"L Perez-Carbonell","year":"2015","unstructured":"Perez-Carbonell L, Sinicrope FA, Alberts SR, Oberg AL, Balaguer F, Castells A, Boland CR, Goel A. MiR-320e is a novel prognostic biomarker in colorectal cancer. Br J Cancer. 2015;113(1):83\u201390.","journal-title":"Br J Cancer"},{"issue":"23","key":"13154_CR54","doi-asserted-by":"publisher","first-page":"11016","DOI":"10.1111\/jcmm.17024","volume":"25","author":"J Qi","year":"2021","unstructured":"Qi J, Zhang R, Wang Y. Exosomal miR-21-5p derived from bone marrow mesenchymal stem cells promote osteosarcoma cell proliferation and invasion by targeting PIK3R1. J Cell Mol Med. 2021;25(23):11016\u201330.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"13154_CR55","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3390\/ijms18030573","volume":"18","author":"D Dayde","year":"2017","unstructured":"Dayde D, Tanaka I, Jain R, Tai MC, Taguchi A. Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer. Int J Mol Sci. 2017;18(3):573.","journal-title":"Int J Mol Sci"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-13154-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-13154-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-13154-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T13:03:05Z","timestamp":1731762185000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-13154-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,16]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["13154"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-13154-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,16]]},"assertion":[{"value":"26 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent and approval were obtained from all the patients and the Ethics Committee of The First Affiliated Hospital of Hebei North University (K2022058). The research was conducted in accordance with the guidelines of the Ethics Committee listed in the Ethics Statement. Patients signed informed consent regarding publishing their data and images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s parent for publication of this case report and the accompanying images. A copy of the written consent obtained from the parent of the patient in this case report is available for review by the editorial office of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1413"}}